دورية أكاديمية
أعرض في EDS

Axillary Management: How Much Is Too Much?

التفاصيل البيبلوغرافية
العنوان: Axillary Management: How Much Is Too Much?
المؤلفون: Owusu-Brackett N; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Facer B; Department of Radiation Oncology, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Quiroga D; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Pariser A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Grimm M; West Virginia University School of Medicine, Morgantown, WV, USA., Beyer S; Department of Radiation Oncology, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Jhawar S; Department of Radiation Oncology, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA., Oppong BA; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, USA. bridget.oppong@osumc.edu.
المصدر: Current oncology reports [Curr Oncol Rep] 2024 Jul; Vol. 26 (7), pp. 735-743. Date of Electronic Publication: 2024 May 15.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Current Science, c1999-
مواضيع طبية MeSH: Axilla* , Breast Neoplasms*/pathology , Breast Neoplasms*/surgery , Breast Neoplasms*/drug therapy , Sentinel Lymph Node Biopsy* , Lymph Node Excision*, Humans ; Female ; Neoadjuvant Therapy ; Lymphatic Metastasis ; Lymph Nodes/pathology ; Lymph Nodes/surgery
مستخلص: Purpose of Review: To review the current management of the axilla in breast cancer.
Recent Findings: Axillary dissection is no longer indicated in patients with clinically node-negative axilla with 1-2 positive sentinel lymph nodes following upfront surgery or in patients with clinically node-negative axilla following neoadjuvant chemotherapy. Breast cancer has evolved away from routine axillary clearance to the less invasive sentinel lymph node biopsy to now complete omission of axillary sampling in select patients. We will review the most salient evidence that has shaped these practice changes over the last three decades. Current practice controversies are especially relevant for elderly populations and those receiving neoadjuvant therapy. Ongoing clinical trials will provide data to further guide breast cancer surgical management.
(© 2024. The Author(s).)
References: J Clin Oncol. 2006 Jan 20;24(3):337-44. (PMID: 16344321)
Ann Surg Oncol. 2014 Mar;21(3):717-30. (PMID: 24473640)
J Clin Oncol. 2012 May 20;30(15):1796-804. (PMID: 22508812)
J Clin Oncol. 2014 Nov 10;32(32):3600-6. (PMID: 25135994)
Lancet Oncol. 2018 Jan;19(1):27-39. (PMID: 29242041)
Ann Surg Oncol. 2018 May;25(5):1329-1339. (PMID: 29468606)
Breast J. 2021 Apr;27(4):335-344. (PMID: 33709448)
Lancet Oncol. 2012 Jan;13(1):25-32. (PMID: 22153890)
Ann Surg. 1994 Sep;220(3):391-8; discussion 398-401. (PMID: 8092905)
JCO Precis Oncol. 2022 Sep;6:e2200148. (PMID: 36170624)
J Clin Oncol. 2017 Feb 10;35(5):561-564. (PMID: 27937089)
JAMA. 2013 Oct 9;310(14):1455-61. (PMID: 24101169)
Ann Surg. 2016 Sep;264(3):413-20. (PMID: 27513155)
J Clin Oncol. 2015 Jan 20;33(3):258-64. (PMID: 25452445)
Br J Cancer. 1948 Mar;2(1):7-13. (PMID: 18863724)
J Surg Oncol. 2010 Aug 1;102(2):111-8. (PMID: 20648579)
J Clin Oncol. 2016 Apr 1;34(10):1072-8. (PMID: 26811528)
Ann Surg Oncol. 2004 Mar;11(3 Suppl):208S-10S. (PMID: 15023753)
Breast. 2013 Aug;22 Suppl 2:S106-9. (PMID: 24074769)
Cancer. 1958 May-Jun;11(3):611-9. (PMID: 13523570)
N Engl J Med. 2002 Aug 22;347(8):567-75. (PMID: 12192016)
J Clin Oncol. 2010 Sep 1;28(25):3929-36. (PMID: 20679600)
J Geriatr Oncol. 2017 Mar;8(2):140-147. (PMID: 27986500)
J Clin Oncol. 2016 Dec 20;34(36):4431-4442. (PMID: 27646947)
Lancet Oncol. 2014 Nov;15(12):1303-10. (PMID: 25439688)
Ann Surg Oncol. 2017 Nov;24(12):3527-3533. (PMID: 28762114)
JAMA Netw Open. 2020 Nov 2;3(11):e2026921. (PMID: 33211112)
J Am Coll Surg. 2007 Aug;205(2):362-376. (PMID: 17660085)
Ann Surg. 2018 May;267(5):946-951. (PMID: 28549010)
Ann Oncol. 2013 Sep;24(9):2278-84. (PMID: 23704196)
Lancet Oncol. 2013 Jun;14(7):609-18. (PMID: 23683750)
J Clin Oncol. 2013 Jul 1;31(19):2382-7. (PMID: 23690420)
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. (PMID: 31085287)
Clin Radiol. 2018 May;73(5):467-472. (PMID: 29289334)
Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. (PMID: 20739842)
Breast Cancer (Dove Med Press). 2021 May 17;13:311-323. (PMID: 34040436)
N Engl J Med. 2019 Feb 14;380(7):617-628. (PMID: 30516102)
N Engl J Med. 2015 Jul 23;373(4):307-16. (PMID: 26200977)
Ann Surg Oncol. 2018 Oct;25(10):2813-2817. (PMID: 29987610)
Lancet Oncol. 2013 Apr;14(4):297-305. (PMID: 23491275)
N Engl J Med. 2015 Jul 23;373(4):317-27. (PMID: 26200978)
Lancet. 2014 Jul 12;384(9938):164-72. (PMID: 24529560)
N Engl J Med. 1985 Mar 14;312(11):665-73. (PMID: 3883167)
Ann Surg. 1894 Nov;20(5):497-555. (PMID: 17860107)
Am J Surg. 2024 May;231:86-90. (PMID: 38490879)
Ann Surg. 2012 Dec;256(6):920-4. (PMID: 23154393)
N Engl J Med. 2017 Jun 1;376(22):2147-2159. (PMID: 28564564)
J Natl Cancer Inst. 2005 Feb 2;97(3):188-94. (PMID: 15687361)
Lancet Oncol. 2022 Dec;23(12):1517-1524. (PMID: 36306810)
Ann Oncol. 2021 Feb;32(2):229-239. (PMID: 33232761)
N Engl J Med. 2021 Jun 24;384(25):2394-2405. (PMID: 34081848)
J Clin Oncol. 2023 Apr 20;41(12):2159-2165. (PMID: 36383926)
J Clin Oncol. 2008 Mar 10;26(8):1275-81. (PMID: 18250347)
J Clin Oncol. 2008 Feb 10;26(5):778-85. (PMID: 18258986)
J Natl Med Assoc. 2022 Jun;114(3):298-307. (PMID: 35272849)
فهرسة مساهمة: Keywords: Axilla; Breast Cancer; Neoadjuvant Systemic Therapy; Nodal Irradiation; Surgery
تواريخ الأحداث: Date Created: 20240515 Date Completed: 20240704 Latest Revision: 20240707
رمز التحديث: 20240707
مُعرف محوري في PubMed: PMC11224108
DOI: 10.1007/s11912-024-01539-0
PMID: 38748364
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-6269
DOI:10.1007/s11912-024-01539-0